Glutathione depletion and oxidative stress (Q34826188)

4 August 2017

1 reference

title

Glutathione depletion and oxidative stress (English)

1 reference

4 August 2017

1 reference

Catherine Mytilineou

1

1 reference

PubMed ID

12217624

4 August 2017

Brian C Kramer

series ordinal

2

1 reference

PubMed ID

12217624

4 August 2017

Jocelyn A Yabut

series ordinal

3

1 reference

4 August 2017

1 September 2002

1 reference

4 August 2017

3

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

4 August 2017

8

1 reference

4 August 2017

6

1 reference

4 August 2017

385-387

1 reference

Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Induction of intracellular superoxide radical formation by arachidonic acid and by polyunsaturated fatty acids in primary astrocytic cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

1 reference

7 January 2021

Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Phospholipase A2 and its role in brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Selective role of glutathione in protecting human neuronal cells from dopamine-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Protein nitration in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Glutathione deficiency leads to mitochondrial damage in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Oxidative stress and the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Antioxidants, but not cAMP or high K+, prevent arachidonic acid toxicity on neuronal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Arachidonic acid as a neurotoxic and neurotrophic substance

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Failure of the ubiquitin-proteasome system in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Abnormalities of the electron transport chain in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Parkinson's disease: a disorder due to nigral glutathione deficiency?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

The presence of glutathione in primary neuronal and astroglial cultures from rat cerebral cortex and brain stem

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Maintenance of neuronal glutathione by glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Histochemical evaluation of glutathione in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by L-BSO and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900018-4

7 January 2021

10.1016/S1353-8020(02)00018-4

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12217624